BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Business

  Moderna Reports First Quarter 2022 Financial Results and Provides Business Updates

  Moderna, Inc. today reported financial results and provided business updates for the first quarter of fiscal year 2022.

  May 4, 2022

   · 

  36 min read
• Business

  ADMA Biologics to Report First Quarter 2022 Financial Results on May 11, 2022Conference Call Scheduled for May 11, 2022 at 4:30 p.m. ET

  ADMA Biologics, Inc. today announced that it will report financial results for the first quarter ended March 31, 2022 on Wednesday, May 11, 2022, after the U.S. financial markets close.

  May 4, 2022

   · 

  2 min read
• Business

  Oncorus Reports First Quarter 2022 Financial Results and Provides Business Updates

  Oncorus, Inc. (Nasdaq: ONCR), a viral immunotherapies company focused on driving innovation to transform outcomes for cancer patients, today reported first quarter 2022 financial results and highlighted recent achievements and developments.

  May 4, 2022

   · 

  10 min read
• Business

  Amryt Reports Record Q1 2022 Results

  Amryt (Nasdaq: AMYT), a global, commercial-stage biopharmaceutical company dedicated to acquiring, developing and commercializing novel treatments for rare diseases, today provides a business update and announces unaudited financial results for the first quarter ended March 31, 2022.

  May 4, 2022

   · 

  74 min read
• Business

  EyePoint Pharmaceuticals Announces Expanded License Agreement with Betta Pharmaceuticals for EYP-1901 in China, Hong Kong, Macau and Taiwan

  EyePoint Pharmaceuticals, Inc. today announced the execution of a license agreement with Betta Pharmaceuticals Co. Ltd. (SHE: 300558) to develop and commercialize EYP-1901 in Mainland China, Hong Kong, Macau and Taiwan.

  May 4, 2022

   · 

  6 min read
• Drug Development

  Compass Therapeutics Reports Positive Interim Phase 2 Data of CTX-009 in Combination with Paclitaxel in Biliary Tract Cancers

  Compass Therapeutics, Inc. today reported additional interim results from a Phase 2 study of CTX-009 in combination with paclitaxel in patients with biliary tract cancers (BTC). The data show that:

  May 4, 2022

   · 

  9 min read
• Business

  Ionis reports first quarter financial results and recent business achievements

  Ionis Pharmaceuticals, Inc. (Nasdaq: IONS) today reported financial results for the first quarter of 2022 and recent business achievements.

  May 4, 2022

   · 

  17 min read
• Business

  Chemomab Therapeutics to Report First Quarter 2022 Financial Results and Provide a Business Update

  Chemomab Therapeutics Ltd today announced the company will release its first quarter 2022 financial results and provide a business update on Thursday, May 12, 2022.

  May 4, 2022

   · 

  2 min read
• Business

  Amarin Reports First Quarter 2022 Financial Results and Provides Business Update

  Amarin Corporation plc (NASDAQ:AMRN), today announced financial results for the quarter ended March 31, 2022 and provided an update on company operations.

  May 4, 2022

   · 

  25 min read
• Business

  Ben-Gurion University and Soroka Medical Center Announce Strategic Collaboration for Novel Technologies in the Field of Bio-Convergence

  Ben-Gurion University of the Negev (BGU) and Soroka Medical Center announced a strategic collaboration for the development of novel technologies in the filed of Bio-Convergence (a field that combines biology with computational technologies and engineering).

  May 4, 2022

   · 

  7 min read